Table 3 Comparison of antibiotic resistance between ampicillin-resistant and ampicillin-sensitive H. influenzae isolates.

From: Impact of the COVID-19 pandemic on Haemophilus influenzae infections in pediatric patients hospitalized with community acquired pneumonia

Antibiotics

No. (%) of resistant isolates

Ampicillin-resistant isolates (n = 847)

Ampicillin-sensitive isolates (n = 139)

Amoxicillin-clavulanate

189 (22.3)

0 (0.0) ****

Cefaclor

371 (43.8)

1 (0.7) ****

Cefuroxime

365 (43.1)

0 (0.0) ****

Cefotaxime

0 (0.0)

0 (0.0)

Rifampicin

1 (0.1)

0 (0.0)

Ofloxacin

2 (0.2)

0 (0.0)

Tetracycline

60 (7.1)

2 (1.4) **

Chloramphenicol

61 (7.2)

0 (0.0) ****

Trimethoprim-sulfamethoxazole

600 (70.8)

65 (46.8) ****

MDR isolates

379 (44.7)

0 (0.0) ****

  1. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.